Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency [Yahoo! Finance]
Heart Test Laboratories, Inc. (HSCS)
Company Research
Source: Yahoo! Finance
the “Company”) , an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced an analysis published by the Innovation Value Institute (IVI) titled “Introduction of AI assisted Digital Health Technology to Improve Cardiovascular Pathway Efficiency” focused on the MyoVista® wav ECG™'s potential to radically improve the cardiovascular pathway efficiency. Founded in 2006, the Maynooth University, Ireland based IVI is a multidisciplinary research institute focused on digital transformation and technology adoption. The paper analyzed the potential impact of using the MyoVista wav ECG for prescreening of patients being considered for an echocardiographic examination related to left ventricle (LV) function at a National Health Service (NHS) district general hospital. The paper noted that “analysis of the audited figures show that 49.5% of the LV function test queries could poten
Show less
Read more
Impact Snapshot
Event Time:
HSCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSCS alerts
High impacting Heart Test Laboratories, Inc. news events
Weekly update
A roundup of the hottest topics
HSCS
News
- Heart Test Laboratories, Inc. (NASDAQ: HSCS) had its "buy" rating re-affirmed by analysts at Ascendiant Capital Markets. They now have a $15.00 price target on the stock.MarketBeat
- HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial ResultsGlobeNewswire
- HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA SubmissionGlobeNewswire
- HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- HeartSciences Provides Business Update and Reports Fiscal 2024 Financial ResultsGlobeNewswire
HSCS
Sec Filings
- 9/27/24 - Form S-1/A
- 9/26/24 - Form DEFA14A
- 9/18/24 - Form DEF
- HSCS's page on the SEC website